Chihiro Shimazaki

2PUBLICATIONS
10CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda

|Jul 10, 2023
The serum level of plasmin-alpha2 plasmin inhibitor complex (PIC) is useful for differentiating cardiac light chain amyloidosis from transthyretin amyloidosis.

Chihiro Shimazaki, Saori Matsui-Maegawa, Yayoi Kimoto-Matsumura

Pageof 1